On Wednesday, US European stock certificates of deposit were trading up 0.3% at 1,151.24 on the ADR S & P / BNY Mellon Europe Select index.
In continental Europe, the winners were led by biopharmaceutical company DBV Technologies (DBVT) and oil producer Equinor (EQNR), which rose 5.7% and 5% respectively. They were followed by steelmaker ArcelorMittal (MT) and biopharmaceutical company Orphazyme (ORPH), which were up 4.6% and 3.3%.
The biggest drops in continental Europe were biopharmaceutical company Calliditas Therapeutics (CALT) and 3D printing company voxeljet (VJET), which fell 7.9% and 4.3% respectively. Identification technology developer IDEX Biometrics (IDBA) lost 2.6% and telecommunications equipment supplier Nokia (NOK) fell 2.5%.
In the UK and Ireland, the winners were led by oil and gas producer BP (BP) and biopharmaceutical company NuCana (NCNA), which rose 4.5% and 4.2% respectively. They were followed by oil major Royal Dutch Shell (RDS.A) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which gained 2.8% and 2.5%.
In the UK and Irish loss column, biopharmaceuticals MorphoSys (MOR) and Akari Therapeutics (AKTX) fell 1.5% and 1.2% respectively. Educational publisher Pearson (PSO) and cruise line Carnival (CUK) lost 1% and 0.7%.